Celadon Pharmaceuticals PLC (GB:CEL) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Celadon Pharmaceuticals PLC, a UK-based firm specializing in cannabis-based medicines, invites shareholders to visit their West Midlands facility on October 22, 2024. The event, hosted by CEO James Short, will feature a tour, presentation, Q&A session, and refreshments. The company, known for its EU-GMP approved 100,000 sq. ft hydroponic cultivation and R&D laboratory, is at the forefront of developing treatments for chronic pain and autism.
For further insights into GB:CEL stock, check out TipRanks’ Stock Analysis page.